Tottori University · Faculty of Medicine, Department of Medicine · 講師

Research keywords肺癌・癌免疫治療・NKG2Dリガンド

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• DNA-PK inhibition of NU7441 enhances chemosensitivity to topoisomerase inhibitor in Non-small cell lung carcinoma cells by blocking DNA damage repair2017
• A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA(+) oral cancers
• Successful Switch to Afatinib and Osimertinib Rechallenge with Corticosteroids after Osimertinib-induced Interstitial Lung Disease: A Case Report and Literature Review.
• Evaluation of antigen-positive toxin-negative enzyme immunoassay results for the diagnosis of toxigenic Clostridium difficile infection

• 肺扁平上皮癌に対するmTORとFAKを標的とした治療戦略2017
• 悪性胸膜中皮腫のペメトレキセド耐性を克服する新しい治療法の開発
• がん免疫療法 呼吸器免疫学 感染症免疫学 腫瘍免疫学・バイオマーカー探索 NKG2D-NKG2Dリガンド研究
• 肺癌薬物療法の有害事象及び治療効果を予測するバイオマーカーの探索

• Official profile
• ORCID